GlassScriptPhysician profile
Stuart J Bresee
NPI 1386645158
$111,978.74
in general payments reported to CMS, 2019-2025
41 companies · $1,094 in 2025
The $1,094 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $46K · 2020: $11K · 2021: $13K · 2022: $33K · 2023: $6,270 · 2024: $1,226 · 2025: $1,094.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $4,765 · Food and Beverage: $3,779 · Travel and Lodging: $45.85.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $4,765.00 |
| Food and Beverage | $3,779.00 |
| Travel and Lodging | $45.85 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $100,100.96 | 2019-2024 | Xarelto |
| Medtronic Vascular, INC. | $4,124.68 | 2019 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $1,399.52 | 2019-2025 | Lifevest |
| Novartis Pharmaceuticals Corporation | $1,275.36 | 2019-2025 | |
| Abbott Laboratories | $860.86 | 2019-2024 | Pressurewire, Optis, Ensite |
| Boston Scientific Corporation | $729.42 | 2019-2025 | Avvigo Guidance System, Wolverine Coronary Cutting Balloon, Rotapro |
| Amgen INC. | $577.84 | 2019-2025 | Repatha, Repatha |
| Astrazeneca Pharmaceuticals LP | $279.88 | 2020-2023 | Farxiga |
| Pfizer INC. | $261.89 | 2019-2025 | |
| E.R. Squibb & Sons, L.L.C. | $237.86 | 2019-2025 | Camzyos, Eliquis |
| Merck Sharp & Dohme LLC | $159.61 | 2024-2025 | Verquvo |
| Abiomed | $138.48 | 2023 | Impella |
| Mallinckrodt Hospital Products INC. | $135.58 | 2022 | |
| Regeneron Healthcare Solutions, INC. | $127.18 | 2019 | |
| Actelion Pharmaceuticals US, INC. | $119.49 | 2019-2022 |
Show all 41 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cvrx, INC. | $118.55 | 2024 | Barostim Neo System |
| Amarin Pharma, INC. | $116.76 | 2019-2022 | |
| Sanofi-Aventis U.S. LLC | $114.50 | 2019 | |
| Cardiovascular Systems INC. | $102.10 | 2019-2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $95.38 | 2019-2025 | Jardiance |
| Bayer Healthcare Pharmaceuticals INC. | $91.69 | 2025 | |
| Inspire Medical Systems, INC. | $83.14 | 2024-2025 | Inspire |
| Novo Nordisk INC | $71.86 | 2022-2025 | Ozempic |
| Heartflow, INC. | $67.74 | 2025 | |
| Medtronic, INC. | $62.25 | 2021-2024 | Onyx Frontier, Symplicity G3 |
| Philips North America LLC | $57.31 | 2019-2025 | Ambulatory Monitoring & Diagnostics Undivided |
| Chiesi USA, INC. | $56.27 | 2019-2023 | Kengreal, Cleviprex |
| Irhythm Technologies, INC. | $51.68 | 2022-2023 | Zio Xt Patch |
| Scpharmaceuticals INC. | $46.77 | 2025 | |
| Lundbeck LLC | $45.96 | 2019 | |
| Atricure, INC. | $44.83 | 2023 | |
| Cardinal Health 200 LLC | $34.09 | 2019 | |
| Alnylam Pharmaceuticals INC. | $30.43 | 2019-2025 | Amvuttra |
| Biosense Webster, INC. | $26.47 | 2019 | |
| Kiniksa Pharmaceuticals International, Plc | $23.76 | 2024 | Arcalyst |
| Baxter Healthcare | $21.47 | 2023 | Hillrom - Carnation Ambulatory Monitor |
| Zoll Circulation INC | $20.23 | 2023 | Therox Ds2 Console, Downstream Cartridge, Catheter |
| Lantheus Medical Imaging, INC. | $19.52 | 2019 | |
| Dynavax Technologies Corporation | $17.06 | 2025 | Heplisav-B |
| Edwards Lifesciences Corporation | $16.55 | 2025 | |
| Gilead Sciences, INC. | $13.76 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stuart Bresee listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
The CSV has this whole record: totals, yearly figures, every listed company, payment types, and product associations.
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.